Manufacturer Settles Foreign Bribery Allegations Linked To Distributor 'Slush Fund'
This article was originally published in The Gray Sheet
Executive Summary
Analogic Corp. and its subsidiary BK Medical APS are paying almost $15m to settle allegations that BK conspired with distributors to commit fraud overseas.
You may also be interested in...
Medical Device-Makers Face Dynamic Commercial Compliance Risks
Erinn Hutchinson, a Philadelphia-based health industries risk consultant with PricewaterhouseCoopers LLP, talked to Medtech Insight about how she advises medical device companies – big and small – trying to market devices in a dynamic legal compliance environment.
Biomet Still Under Scrutiny For Overseas Bribery
The company came under a Department of Justice inquiry for overseas bribery in 2012, and new allegations in 2014 have delayed a final close-out of the case. The formal agreements expired on March 26, but Biomet says it expects the investigation to continue.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.